Amylin Needs New Leaders on Board, Co-Founder Says
Monday, May 18, 2009
Adding yet another twist to the ongoing proxy fight at Amylin Pharmaceuticals, co-founder Howard Greene last week sided with dissident investors Carl Icahn and Eastbourne Capital Management in encouraging shareholders to vote for new leadership on the board...
Take 1 minute to subscribe and you'll get this story immediately, plus:
Already a subscriber? Sign in

- 52 weekly issues
- Subscriber-only digital content every business day, plus full access to SDBJ.com archives
- Book of Lists — the most comprehensive business resource in San Diego
- San Diego 500 — influential business leaders you need to know